Elevated Respiratory Testing
The Biomiga Respiratory Pathogen Panel (RPP) is a state-of-the-art diagnostic tool designed to assist healthcare providers in swiftly identifying upper respiratory tract infections (URTIs) such as COVID-19, influenza, RSV, and more. This advanced multiplex real-time PCR panel targets a wide array of pathogens, providing clinicians with rapid and precise diagnoses to enhance patient care.
Get the Answers You Need
When symptoms like cough, fever, runny nose, and fatigue arise, diagnosing the underlying cause can be complex and challenging. The Biomiga RPP offers a solution with its quick, actionable results, allowing for improved patient outcomes and effective therapy management. This innovative multiplex molecular test is essential for clinicians looking to provide timely and effective treatment.
Respiratory Testing Menu
Delve into the diverse range of viruses targeted by the Biomiga Respiratory Pathogen Panel, specifically those frequently associated with upper respiratory tract infections.
- Reliable Performance: The Biomiga RPP Panel delivers exceptional sensitivity and specificity for accurate and trustworthy results, making it suitable for nasopharyngeal swabs in transport media or saline.
- Comprehensive Pathogen Coverage: This test targets multiple respiratory pathogens, ensuring a thorough diagnostic evaluation.
Intended Use:
- CE-IVDD Certified
- Approved for use in the USA
Available for research use only (RUO).
Analyte Specific Reagents (ASR) available.
Certificate Overview and Assay Protocol Respiratory Panel Data Sheet
